Polycystic Ovary Syndrome (pcos) - Pharma

Relevant Publications

Anti-Müllerian hormone as a diagnostic biomarker for Polycystic Ovary Syndrome (PCOS) and Polycystic Ovarian Morphology (PCOM): a systematic review and meta-analysis.

Issue Release: 2024

Comparative efficacy of metformin combined with cabergoline versus metformin alone in patients with PCOS and hyperprolactinemia: A systematic review and meta-analysis of randomized controlled trials.

Issue Release: 2024

Common Beverage Consumption and Benign Gynecological Conditions.

Issue Release: 2024

Thyroid autoimmunity in different phenotypes of polycystic ovary syndrome: a single-center experience.

Issue Release: 2024

Vitamin D deficiency, insulin resistance and anti-mullerian hormone: a tale of trio in expression of polycystic ovary syndrome.

Issue Release: 2024

Pretreatment with or without GnRH-agonist before frozen-thawed embryo transfer in patients with PCOS: a systematic review and meta-analysis.

Issue Release: 2024

Genetically predicted high sex hormone binding globulin was associated with decreased risk of polycystic ovary syndrome.

Issue Release: 2024

Dysregulated RNA editing of EIF2AK2 in polycystic ovary syndrome: clinical relevance and functional implications.

Issue Release: 2024

Influence of state-of-the-art laboratory techniques on the phenotyping of women with polycystic ovary syndrome in the clinical setting.

Issue Release: 2024

Polycystic ovary syndrome: A review of diagnosis and management, with special focus on atherosclerotic cardiovascular disease prevention.

Issue Release: 2024

Effects of weight loss intervention on anxiety, depression and quality of life in women with severe obesity and polycystic ovary syndrome.

Issue Release: 2024

[Research progress of chemerin in polycystic ovary syndrome].

Issue Release: 2024

Exploring the Experiential Journey of Women with PCOS Across the Lifespan: A Qualitative Inquiry.

Issue Release: 2024

Changes in the serum metabolomics of polycystic ovary syndrome before and after compound oral contraceptive treatment.

Issue Release: 2024

The relationship between thyroid hormones and insulin resistance in polycystic ovary syndrome women.

Issue Release: 2024

The effect of Bushenhuoxue nutritional decoction in the treatment of overweight patients with polycystic ovarian syndrome.

Issue Release: 2024

Metformin modifies plasma microbial-derived extracellular vesicles in polycystic ovary syndrome with insulin resistance.

Issue Release: 2024

Prevalence and correlates of diagnosed and probable polycystic ovary syndrome (PCOS) in a cohort of parous women.

Issue Release: 2024

Development of an Endoplasmic Reticulum Stress-Related Diagnostic Signature in Polycystic Ovary Syndrome.

Issue Release: 2024

The latest reports and treatment methods on polycystic ovary syndrome.

Issue Release: 2024

What is the Future of Patient Education in Pharma?

What Are the Challenges of Clinical Trials?

What Challenges Do Pharmacists Face?

What Are the Challenges in Managing Chronic Conditions?

How Does Cellular Stress Impact Drug Development?

What Are Clinical Trials?

What Role Does Technology Play?

Why are Collaborative Care Models Important in Pharma?

Why is Patient Education Important?

What Types of Medications are Used?

Partnered Content Networks

Relevant Topics